Trevena
TRVN
#10608
Rank
A$0.01 M
Marketcap
A$0.01804
Share price
0.00%
Change (1 day)
-99.28%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -A$46.06 Million

According to Trevena's latest financial reports the company's current earnings are A$0.54 Million. In 2023 the company made an earning of -A$54.63 Million, an increase over its 2022 earnings that were of -A$78.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$46.06 Million-15.68%
2023 -A$54.63 Million-30.69%
2022 -A$78.82 Million1.38%
2021 -A$77.75 Million78.04%
2020 -A$43.67 Million21.3%
2019 -A$36 Million-13.91%
2018 -A$41.82 Million-59.75%
2017 -A$0.11 Billion-31.77%
2016 -A$0.16 Billion101.73%
2015 -A$75.48 Million1.14%
2014 -A$74.63 Million114.83%
2013 -A$34.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.39 B-26,645.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.14 Billion 2,321.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-A$94.43 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.72 B-74,449.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.95 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-A$15.47 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA